Neoplasia

21 papers6 directions
Neoplasia is a research venue that has been active from 2005 to 2025, focusing primarily on oncology, cancer biology, and molecular medicine. While its core mission centers on the biological mechanisms of cancer, it serves as a site for interdisciplinary research that incorporates computational pathology and data-driven analysis. The venue publishes work on a diverse array of malignancies, including hepatocellular carcinoma, ovarian clear cell carcinoma, and non-small cell lung cancer. In the context of machine learning and artificial intelligence, Neoplasia features research that applies computational models to clinical and genomic data. This includes the use of single-source dual-energy CT (ssDECT) for assessing immunotherapy responses and the application of systematic analysis to global health datasets, such as the Global Burden of Disease Study. The venue also hosts studies on genomic characterization and mutation patterns, utilizing whole exome sequencing to identify driver genes and evolutionary subtypes in various cancers. The venue's contributions are supported by researchers such as Benjamin Haibe-Kains, Christine Decaestecker, and Gianluca Bontempi, who are active in bioinformatics and computational biology. By publishing studies that integrate preclinical models with computational applications, Neoplasia facilitates the development of quantitative methods for understanding chemoresistance, signaling pathways, and tumor microenvironments. This intersection of molecular oncology and computational science positions the venue as a resource for researchers applying data-centric methodologies to complex biological problems.

Papers by Year

2025 2
2024 3
2020 2
2019 2
2018 1
2017 1
2012 1
2011 1
2010 2
2009 2
2008 2
2007 1
2005 1

Top Research Directions

Research directions most represented by papers from this venue.

Stepwise Selection for Modeling Acquired Drug Resistance 1
Marginal Dependency Decoupling via Copula Functions 1
Unsupervised Discovery of Latent Clinical Phenotypes 1
Targeting Infiltrative Growth and Resistance Mechanisms in Glioma 1
Molecular Mechanisms of Resistance to Platinum Chemotherapy 1
Overcoming Unimodal Constraints through Multimodal Neuroimaging Integration 1

Top Authors

AuthorPapers
Benjamin Haibe-Kains5
Alexander Baras1
Carola-Bibiane Schönlieb1
Chao Li1
ELISA FICARRA1

Impactful Papers

Papers from this venue that shaped research clusters.

Foundational

Related Venues

Venues with the most similar research cluster distributions.

Papers

TitleYear
An effective multistage mouse model of esophageal carcinogenesis for preclinical and computational pathology applications2025
L-methionine promotes CD8+ T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling2025
Incidence, mortality, and global burden of retinoblastoma in 204 countries worldwide from 1990 to 2021: Data and systematic analysis from the Global Burden of Disease Study 20212024
PIK3R1 fusion drives chemoresistance in ovarian cancer by activating ERK1/2 and inducing rod and ring-like structures2024
Tumor microenvironment(TME) and single-source dual-energy CT(ssDECT) on assessment of inconformity between RECIST1.1 and pathological remission in neoadjuvant immunotherapy of NSCLC2024
Genomic characterization of Chinese ovarian clear cell carcinoma identifies driver genes by whole exome sequencing2020
Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes2020
Decoding the Interdependence of Multiparametric Magnetic Resonance Imaging to Reveal Patient Subgroups Correlated with Survivals2019
Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma2019
Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology2018
Proteomic Characterization of Prostate Cancer to Distinguish Nonmetastasizing and Metastasizing Primary Tumors and Lymph Node Metastases2017
Identification of Cell Surface Targets through Meta-analysis of Microarray Data2012
Use of Yeast Chemigenomics and COXEN Informatics in Preclinical Evaluation of Anticancer Agents2011
Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression2010
Long-term Temozolomide Treatment Induces Marked Amino Metabolism Modifications and an Increase in TMZ Sensitivity in Hs683 Oligodendroglioma Cells2010
Galectin 1 Proangiogenic and Promigratory Effects in the Hs683 Oligodendroglioma Model Are Partly Mediated through the Control of BEX2 Expression2009
N-myc Downstream Regulated Gene 1 (NDRG1) Is Fused to ERG in Prostate Cancer2009
Aberrant Transforming Growth Factor β1 Signaling and SMAD4 Nuclear Translocation Confer Epigenetic Repression of ADAM19 in Ovarian Cancer2008
UNBS5162, a Novel Naphthalimide That Decreases CXCL Chemokine Expression in Experimental Prostate Cancers2008
4-IBP, a σ1 Receptor Agonist, Decreases the Migration of Human Cancer Cells, Including Glioblastoma Cells, In Vitro and Sensitizes Them In Vitro and In Vivo to Cytotoxic Insults of Proapoptotic and Pr2007
Patients with High-Grade Gliomas Harboring Deletions of Chromosomes 9p and 10q Benefit from Temozolomide Treatment2005